Publications by authors named "Petra Hasengruber"

Claim this Profile
T
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Ameya Kunte, Christina Groiss, Lorenz Mair, Petra Hasengruber

Cell Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
Alexander Nikoloudis, Anna Bauhofer, Lena Griessl, Anke Habermehl, Christina Groiss, Petra Hasengruber

Cytotherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.
Christina Groiss, Stefanie Kreissl, Irene Strassl, Olga Saini, Dagmar Wipplinger, Petra Hasengruber

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber

Cytotherapy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Recipient's Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients.
Alexander Nikoloudis, Helga Wagner, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Irene Strassl, Petra Hasengruber

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis